ArticleJournal of inflammation research2025
Immune Response to TB Antigen Stimulation in Type 2 Diabetes Mellitus: Insights from a Cross-Sectional Cytokine Profile Analysis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The syndemic of tuberculosis (TB) and type 2 diabetes mellitus (T2DM) presents a growing global health challenge, particularly in high-burden countries. T2DM is known to impair immune responses, increasing susceptibility to TB. However, the cytokine dynamics underlying this interaction remain unclear. This study aimed to explore the differences in ex vivo cytokine responses between individuals with and without T2DM following TB antigen stimulation. Patients and Methods: In this cross-sectional study, we analyzed plasma samples from 110 individuals with T2DM and 38 without, collected as part of the TANDEM and INFECT cohort studies in Indonesia. Cytokine levels (IL-1β, IL-6, TNF-α, and IFN-γ) were measured using ELISA before and after TB antigen stimulation using the QuantiFERON-TB Gold assay. Demographic, clinical, and metabolic parameters were recorded. Statistical analyses included Mann-Whitney Results: Patients with DM showed a higher baseline levels of pro-inflammatory cytokines than non-DM individuals, particularly in IL-1β, IL-6 and TNF-α, suggesting a primed immune response even before TB antigen exposure. After TB antigen stimulation, no significant between-group differences were observed in cytokine levels. However, IL-1β showed a more pronounced median increase in T2DM (124 vs -54 pg/mL, p = 0.43), while IL-6, TNF-α, and IFN-γ changes were blunted in the T2DM group. Correlation analyses revealed that in T2DM individuals, IL-1β positively correlated with IL-6 and TNF-α both pre- and post-stimulation. IL-6 and IFN-γ showed significant associations with HbA1c and BMI in the non-DM group. Conclusion: T2DM group exhibited altered immune patterns marked by heightened IL-1β response and disrupted regulation of IL-6, TNF-α, and IFN-γ, although no statistically significant cytokine differences were observed. These findings suggest an immune dysregulation in T2DM that may contribute to TB susceptibility, warranting further investigation using CD4/CD8-responsive assays in larger, more diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.